STEVEN EISENSTEIN: Open Payments
NPI 1811905466 · FARMVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,645 in 183 payments from 11 companies in 2025. Trend: 2023 $2,102 · 2024 $2,720 · 2025 $3,645
Food & beverage: $3,484Education: $161
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 34 | $698 |
| Teva Pharmaceuticals USA, Inc. | 25 | $663 |
| Janssen Pharmaceuticals, Inc | 25 | $620 |
| Otsuka America Pharmaceutical, Inc. | 22 | $342 |
| Axsome Therapeutics, Inc. | 11 | $251 |
| Vanda Pharmaceuticals Inc. | 13 | $241 |
| Neurocrine BioSciences, Inc. | 11 | $207 |
| Alkermes, Inc. | 15 | $190 |
| E.R. Squibb & Sons, L.L.C. | 11 | $188 |
| Lundbeck LLC | 12 | $168 |
Products named: CAPLYTA, INVEGA SUSTENNA, UZEDY, REXULTI, Auvelity, INGREZZA, COBENFY, HETLIOZ.
Industry payments across VA — which companies pay providers there.
